Current stage?-Stage II - Page 17 of 30 Posts on Medivizor
Navigation Menu

Current stage?-Stage II Posts on Medivizor

HER2 testing – is it imperative?

HER2 testing – is it imperative?

Posted by on May 29, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to identify the impact of trastuzumab on cardiac (heart) function when treatment was not specifically restricted to those with human epidermal growth factor receptor 2 positive (HER2+) breast cancer.  Some background Trastuzumab is a type of targeted drug used to treat breast cancer. Specifically, it targets...

Read More

Fifteen-year outcomes following conservative management of prostate cancer

Fifteen-year outcomes following conservative management of prostate cancer

Posted by on May 29, 2015 in Prostate cancer | 0 comments

In a nutshell This study investigated the long-term outcomes of conservative management of localized prostate cancer in men aged 65 and over. Some background Increased levels of prostate specific antigen (PSA; a protein elevated in prostate cancer) screening is allowing the detection of prostate cancer when it has not yet spread to other parts of...

Read More

Is the removal of the breast a reliable treatment for women with low-risk early breast cancer?

Is the removal of the breast a reliable treatment for women with low-risk early breast cancer?

Posted by on May 20, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to study the best course of surgical treatment for women with low-risk early breast cancer. Some background Breast-conserving therapy (the removal of the tumor and some surrounding breast tissue) is often recommended for women with early breast cancer. It is generally followed by radiation therapy (using radiation...

Read More

Chemotherapy before surgery; is there a different in outcome between different types of breast cancer?

Chemotherapy before surgery; is there a different in outcome between different types of breast cancer?

Posted by on May 14, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to evaluate if the outcomes of surgery following chemotherapy are different based on the focality of breast cancer tumors.  Some background Breast cancer can be characterised as 'unifocal', 'multifocal and 'multicentric'. This refers to the number of areas in which the cancer can be found...

Read More

Can PDE5 inhibitors increase the risk of cancer recurrence after prostate surgery?

Can PDE5 inhibitors increase the risk of cancer recurrence after prostate surgery?

Posted by on May 5, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine the effect of phosphodiesterase type 5 inhibitors on cancer recurrence in patients after prostate surgery. Some background Prostate surgery is a form of treatment that involves surgically removing the prostate gland in patients with prostate cancer. Some patients may experience erectile dysfunction...

Read More

Can levels of antimullerian hormone predict when patients with breast cancer regain ovarian function?

Can levels of antimullerian hormone predict when patients with breast cancer regain ovarian function?

Posted by on Apr 28, 2015 in Breast cancer | 0 comments

In a nutshell This paper studied whether levels of antimullerian hormone, follicle stimulating hormone and inhibin B could predict when the ovaries regain function after chemotherapy.  Some background Chemotherapy is used to treat breast cancer. However, it can cause damage to the ovaries and affect fertility. Thus, it would be useful for...

Read More

Is there any need for trastuzumab after surgery if you received trastuzumab before surgery?

Is there any need for trastuzumab after surgery if you received trastuzumab before surgery?

Posted by on Apr 28, 2015 in Breast cancer | 0 comments

In a nutshell This paper studied the effect of adjuvant therapy (treatment given after surgery) in patients who had a complete response to therapy with trastuzumab (Herceptin) before surgery.  Some background Neoadjuvant systemic therapy is treatment used to decrease the size of the tumour before surgery. An example of treatment...

Read More

Proteins can predict bone tumors and survival in hormone-resistant prostate cancer

Proteins can predict bone tumors and survival in hormone-resistant prostate cancer

Posted by on Apr 24, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine whether specific proteins can predict bone tumors and death in patients with hormone-resistant prostate cancer.  Some background In advanced prostate cancer, tumors can spread out from the initial site of cancer to other parts of the body and bones, making treatment difficult. Hormone therapy...

Read More